Concurrent protective and destructive signaling of JNK2 in neuroblastoma cells.

[1]  T. Herdegen,et al.  All JNKs Can Kill, but Nuclear Localization Is Critical for Neuronal Death* , 2008, Journal of Biological Chemistry.

[2]  C. Teng,et al.  Moscatilin Induces Apoptosis in Human Colorectal Cancer Cells: A Crucial Role of c-Jun NH2-Terminal Protein Kinase Activation Caused by Tubulin Depolymerization and DNA Damage , 2008, Clinical Cancer Research.

[3]  E. Wagner,et al.  Targeting c-Jun and JunB proteins as potential anticancer cell therapy , 2008, Oncogene.

[4]  S. Krupenko,et al.  Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway , 2007, Oncogene.

[5]  S. Leivonen,et al.  EGF‐R regulates MMP function in fibroblasts through MAPK and AP‐1 pathways , 2007, Journal of cellular physiology.

[6]  Wancai Yang,et al.  c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression. , 2007, The American journal of pathology.

[7]  Wancai Yang,et al.  JNK1 is required for sulindac-mediated inhibition of cell proliferation and induction of apoptosis in vitro and in vivo. , 2007, European journal of pharmacology.

[8]  Yumei Fan,et al.  c-Jun NH2-terminal kinase decreases ubiquitination and promotes stabilization of p21(WAF1/CIP1) in K562 cell. , 2007, Biochemical and biophysical research communications.

[9]  Deborah L. Johnson,et al.  TBP Is Differentially Regulated by c-Jun N-Terminal Kinase 1 (JNK1) and JNK2 through Elk-1, Controlling c-Jun Expression and Cell Proliferation , 2007, Molecular and Cellular Biology.

[10]  Chao Zhang,et al.  JNK2 is a positive regulator of the cJun transcription factor. , 2006, Molecular cell.

[11]  C. Ra,et al.  Growth suppression of human mast cells expressing constitutively active c‐kit receptors by JNK inhibitor SP600125 , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[12]  Shivendra V. Singh,et al.  c-Jun NH2-Terminal Kinase Signaling Axis Regulates Diallyl Trisulfide–Induced Generation of Reactive Oxygen Species and Cell Cycle Arrest in Human Prostate Cancer Cells , 2006 .

[13]  M. Coleman,et al.  Stability of p21Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton , 2006, Oncogene.

[14]  R. Lotan,et al.  N-(4-Hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells , 2006, Oncogene.

[15]  G. Firestone,et al.  3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells. , 2006, Cancer research.

[16]  T. Herdegen,et al.  JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length , 2006, The Journal of cell biology.

[17]  M. Leist,et al.  A role for mixed lineage kinases in granule cell apoptosis induced by cytoskeletal disruption , 2006, Journal of neurochemistry.

[18]  David A. Hume,et al.  The JNK Are Important for Development and Survival of Macrophages , 2006, The Journal of Immunology.

[19]  R. Coombes,et al.  Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. , 2006, Cancer research.

[20]  A. Kong,et al.  p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1 , 2006, Cancer Chemotherapy and Pharmacology.

[21]  T. Herdegen,et al.  Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. , 2005, Trends in pharmacological sciences.

[22]  T. Herdegen,et al.  MEKK1 controls neurite regrowth after experimental injury by balancing ERK1/2 and JNK2 signaling , 2005, Molecular and Cellular Neuroscience.

[23]  J. Filén,et al.  Constitutively Active Cytoplasmic c-Jun N-Terminal Kinase 1 Is a Dominant Regulator of Dendritic Architecture: Role of Microtubule-Associated Protein 2 as an Effector , 2005, The Journal of Neuroscience.

[24]  Robert A. Winn,et al.  Restoration of Wnt-7a Expression Reverses Non-small Cell Lung Cancer Cellular Transformation through Frizzled-9-mediated Growth Inhibition and Promotion of Cell Differentiation* , 2005, Journal of Biological Chemistry.

[25]  G. K. Bilter,et al.  Inhibition of Tumor Growth, Angiogenesis, and Tumor Cell Proliferation by a Small Molecule Inhibitor of c-Jun N-terminal Kinase , 2005, Journal of Pharmacology and Experimental Therapeutics.

[26]  E. Wagner,et al.  Specific pathophysiological functions of JNK isoforms in the brain , 2005, The European journal of neuroscience.

[27]  D. Engelberg.  Stress-activated protein kinases-tumor suppressors or tumor initiators? , 2004, Seminars in cancer biology.

[28]  M. Jäättelä,et al.  JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways , 2004, Cell Death and Differentiation.

[29]  M. Karin,et al.  The control of cell motility and epithelial morphogenesis by Jun kinases. , 2004, Trends in cell biology.

[30]  Amy M Mingo-Sion,et al.  Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells , 2004, Oncogene.

[31]  S. Grösch,et al.  Activation of c‐Jun‐N‐terminal‐kinase is crucial for the induction of a cell cycle arrest in human colon carcinoma cells caused by flurbiprofen enantiomers , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  R. Schwabe,et al.  c‐Jun‐N‐terminal kinase drives cyclin D1 expression and proliferation during liver regeneration , 2003, Hepatology.

[33]  M. Miloso,et al.  Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells , 2003, Neurochemistry International.

[34]  M. Ailenberg,et al.  Cytochalasin D disruption of actin filaments in 3T3 cells produces an anti-apoptotic response by activating gelatinase A extracellularly and initiating intracellular survival signals. , 2003, Biochimica et biophysica acta.

[35]  T. Herdegen,et al.  A Single c-Jun N-terminal Kinase Isoform (JNK3-p54) Is an Effector in Both Neuronal Differentiation and Cell Death* , 2003, The Journal of Biological Chemistry.

[36]  J. Rhim,et al.  C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  S. Pelech,et al.  Nocodazole-induced p53-dependent c-Jun N-terminal Kinase Activation Reduces Apoptosis in Human Colon Carcinoma HCT116 Cells* , 2002, The Journal of Biological Chemistry.

[38]  E. Friedman,et al.  The Stress-activated Protein Kinases p38α and JNK1 Stabilize p21Cip1 by Phosphorylation* , 2002, The Journal of Biological Chemistry.

[39]  A. Bode,et al.  Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. , 2002, Cancer research.

[40]  Z. Xia,et al.  Taxol Induces Apoptosis in Cortical Neurons by a Mechanism Independent of Bcl-2 Phosphorylation , 2001, The Journal of Neuroscience.

[41]  Weiya Ma,et al.  Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. , 2001, Cancer research.

[42]  M. Gorospe,et al.  Inhibition of c-Jun N-Terminal Kinase 2 Expression Suppresses Growth and Induces Apoptosis of Human Tumor Cells in a p53-Dependent Manner , 2000, Molecular and Cellular Biology.

[43]  W. Rom,et al.  Role of c-Jun N-terminal kinase 1 (JNK1) in cell cycle checkpoint activated by the protease inhibitor N-acetyl-leucinyl-leucinyl-norleucinal , 1999, Oncogene.

[44]  I. Ferrer,et al.  Localization and expression of Jun-like immunoreactivity in apoptotic neurons induced by colchicine administration in vivo and in vitro depends on the antisera used , 1999, Acta Neuropathologica.

[45]  T. Garrington,et al.  MEK Kinase 1 (MEKK1) Transduces c-Jun NH2-terminal Kinase Activation in Response to Changes in the Microtubule Cytoskeleton* , 1999, The Journal of Biological Chemistry.

[46]  O. Potapova,et al.  The Jun Kinase 2 Isoform Is Preferentially Required for Epidermal Growth Factor-Induced Transformation of Human A549 Lung Carcinoma Cells , 1999, Molecular and Cellular Biology.

[47]  R. Davis,et al.  Signal transduction by the c-Jun N-terminal kinase. , 1999, Biochemical Society symposium.

[48]  V. Baldin,et al.  Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line , 1997, Oncogene.

[49]  K. Unsicker,et al.  Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: Correlation with expression of growth factors and growth factor receptors , 1995, Journal of neuroscience research.